Rick Simpson Oil (RSO) in Alexander County, Illinois: The Complete Guide by OilWell Cannabis

If you’re reading this in Cairo, Thebes, Tamms, or anywhere across Alexander County, you already know what it means to face challenges head-on. Our corner of southern Illinois—pressed against the Mississippi River, shaped by agricultural roots and hard-won resilience—has never been a place where people wait around for solutions. When the medical system falls short, when chronic pain becomes a daily companion, when sleepless nights stretch into weeks, Alexander County folks do what they’ve always done: they research, they ask tough questions, and they find answers that work for them.

That’s exactly why we created this guide. Rick Simpson Oil has become one of the most searched cannabis terms across southern Illinois—people in Cairo are looking for it, folks in Thebes are asking about it, and patients throughout Alexander County are trying to understand what it actually does. Most of what you’ll find online is either hype-driven marketing or outdated misinformation. We’re here to change that.

We at OilWell Cannabis have spent years building something different: a complete, evidence-based RSO education built on real science, real stories, and real transparency. We publish our exact formulas openly. We cite every study. And we serve Alexander County residents with the same dedication we show our Houston neighbors—through legal, Farm Bill-compliant shipping that brings lab-tested, multi-cannabinoid products directly to your door.

This isn’t a sales pitch. It’s the guide we wish existed when we started this journey. Whether you’re a cancer patient exploring supportive options, a veteran with PTSD seeking alternatives, a caregiver in Tamms researching for a loved one, or simply curious about what RSO actually is—this is for you. No snake oil. No false hope. Just the complete truth about Rick Simpson Oil, adapted specifically for Alexander County’s needs.

Who Was Rick Simpson? The Real Story Behind the Name

Rick Simpson was born in 1949 in Amherst, Nova Scotia, Canada. He wasn’t a doctor, scientist, or medical professional—he was a power engineer and maintenance worker, a blue-collar tradesman whose path into cannabis advocacy began not with research but with personal suffering and a deep distrust of the medical system that failed him. That story resonates across Alexander County, where many of us have felt the frustration of a healthcare system that sometimes leaves rural residents with more questions than answers.

In 1997, while working at a hospital in Moncton, New Brunswick, Simpson fell from scaffolding and suffered a serious head injury. The aftermath included persistent tinnitus, dizziness, and a constellation of post-concussion symptoms that conventional medicine could not adequately resolve. According to Simpson, the medications he was prescribed either failed to help or made his condition worse. He reported that cannabis provided more relief than anything his doctors offered, but when he asked his physician to support or prescribe cannabis, the request was refused .

Simpson’s interest in concentrated cannabis oil deepened after he learned about a 1974 study funded by the National Institute of Health and conducted at the Medical College of Virginia, in which THC was reported to slow or shrink tumors in mice. That study—originally intended to demonstrate harm—became a foundational reference point in Simpson’s later advocacy, even though its findings were never replicated in controlled human cancer trials .

The pivotal moment in Simpson’s story came in 2003. He reported that three bumps on his arm were diagnosed by his doctor as basal cell carcinoma. Rather than pursuing conventional treatment, Simpson applied concentrated cannabis oil directly to the lesions, covered them with bandages, and waited. According to his account, the bumps disappeared within four days. No independent medical verification of this outcome has been published, and no biopsy confirmation or clinical follow-up has been documented in any peer-reviewed source. Nevertheless, this personal experience became the origin story of Rick Simpson Oil and the foundation of everything that followed .

Important context: Simpson’s account is presented here as his personal testimony. The absence of clinical documentation, controlled observation, or independent medical confirmation means these events cannot be evaluated as medical evidence. They are, however, historically significant as the catalyst for a global movement.

The Traditional RSO Protocol: Understanding the 60-Gram Regimen

Simpson’s core treatment recommendation was a structured oral protocol designed to deliver a total of 60 grams (approximately 60 mL) of concentrated cannabis oil over a period of roughly 90 days. He described this as a cancer treatment protocol, though he also recommended it for numerous other conditions. For Alexander County residents researching dosing protocols online, this is the regimen you’ll most frequently encounter in forums and patient communities. Here’s exactly what it entails:

Goal

Consume 60 grams of concentrated, high-THC cannabis oil over approximately 90 days. Simpson considered this the minimum amount necessary for a serious cancer treatment course.

Titration Schedule

• Week 1: Begin with a dose approximately the size of half a grain of dry rice—roughly 10 to 15 milligrams of oil—taken three times per day (morning, afternoon, and before bed). Total daily intake during this phase: approximately 30 to 45 milligrams.

• Weeks 2 through 5: Double the dose approximately every four days. The purpose of the slow ramp-up was to build THC tolerance gradually and minimize disruption from the psychoactive effects. By the end of this escalation period—roughly four to five weeks in—the target was to reach approximately 1 gram (1,000 milligrams) of oil per day, divided into three roughly equal doses.

• Weeks 5 through 12: Maintain the full dose of approximately 1 gram per day, divided into three doses of roughly 333 milligrams each, and continue until the full 60 grams have been consumed. At this dosing level, the remaining 50-plus grams of oil would be consumed over the final seven to eight weeks.

Administration Methods

• Primary method—oral: Simpson recommended placing the dose directly under the tongue (sublingual) or swallowing it. He considered oral ingestion the most important route for systemic absorption and the primary method for internal cancers and other systemic conditions.

• Secondary method—topical: For skin cancers and external lesions, Simpson recommended applying the oil directly to the affected area, covering it with a bandage, and changing the bandage every three to four days. He combined topical application with oral dosing for skin cancers.

• Not recommended as primary—inhalation: Simpson did not recommend smoking or vaporizing the oil as a primary treatment method. He acknowledged inhalation for immediate symptom relief (pain, nausea) but maintained that the oral route was necessary for the sustained, high-dose exposure he considered therapeutically essential.

Tolerance and Psychoactive Effects

• Simpson maintained that patients would develop significant tolerance to the psychoactive effects of THC within approximately three to four weeks of consistent dosing at escalating levels.
• He considered the euphoric, sedating, or disorienting effects a minor and temporary side effect and strongly urged patients not to let the high discourage them from continuing the protocol.
• He recommended that patients take their initial doses at night or before bed to sleep through the most intense psychoactive effects during the early titration phase.
• Simpson also recommended that patients avoid driving or operating machinery during the titration period and that they inform family members about what to expect.

Important context for evaluating this protocol: This protocol was designed by one person based on his personal experience and anecdotal observations. It was not developed through clinical trials, dose-finding studies, pharmacokinetic modeling, or any formal research process. Several critical points apply:

• No controlled trial validation. There are no published randomized controlled trials, cohort studies, or even well-documented case series evaluating this specific 60-gram/90-day protocol for any cancer type or any other condition.
• Assumes crude, unstandardized material. The 60-gram quantity assumes a single-strain, THC-dominant extract with no standardized potency. Actual THC content per gram of traditional RSO varied widely depending on the starting plant material and extraction technique.
• Very high THC exposure. At the peak dosing phase, patients were consuming roughly 1 gram of high-THC oil per day. Assuming traditional RSO contained 60 to 90 percent THC, this translates to approximately 600 to 900 milligrams of delta-9 THC per day—a dose far exceeding anything studied in controlled clinical settings.
• Real risks at these doses. Consuming 600 to 900 milligrams of THC daily carries serious risks including severe intoxication, impairment, anxiety, panic, tachycardia, hypotension, and cannabis use disorder [1][13][14][15].
• Oncology context. Patients with active cancer are often medically complex. Using unregulated, unstandardized cannabis oil as a primary cancer treatment—potentially in place of proven therapies—introduces harm that extends beyond the oil itself.

What Traditional RSO Actually Was: The Product

Traditional RSO refers to the specific type of concentrated cannabis oil that Simpson made and advocated for. It was defined not by lab specifications or regulatory standards but by his method and materials. For Alexander County residents who may encounter products labeled “RSO” at dispensaries or online, it’s crucial to understand what the original product actually was:

Source Material

Simpson used high-THC, indica-dominant cannabis strains. He specifically favored heavy, sedating indica genetics and generally recommended against sativa-dominant strains for cancer treatment, believing that indica strains produced better therapeutic outcomes. He grew his own cannabis or sourced it from growers he trusted. There was no strain standardization—the starting material varied by availability and growing season.

Extraction Solvent

Simpson originally used naphtha—a petroleum-based solvent commercially available as lighter fluid, Varsol, or similar products. He later also endorsed 99 percent isopropyl alcohol as an acceptable alternative. He explicitly warned against using other solvents, including butane or acetone, due to safety and purity concerns. Neither naphtha nor isopropyl alcohol is a food-grade solvent, which is a significant safety issue.

Extraction Process

1. Dry or semi-dry cannabis plant material was placed in a container (typically a bucket).
2. The material was covered with solvent and agitated or stirred for several minutes to dissolve cannabinoids and other fat-soluble compounds from the plant.
3. The solvent was poured off through a filter, typically cheesecloth or a similar mesh material, into a separate collection vessel.
4. The process was repeated a second time with fresh solvent on the same plant material to extract remaining cannabinoids.
5. The combined solvent washes—now a dark, cannabinoid-rich liquid—were placed in a rice cooker or similar open-vessel heating device.
6. The solvent was evaporated at relatively low heat. Simpson recommended a rice cooker specifically because it maintains a temperature range that evaporates the solvent without exceeding the point at which cannabinoids degrade significantly. However, this temperature was still high enough to decarboxylate THCa into THC and to destroy most volatile terpenes.
7. As the solvent evaporated, a thick, dark oil remained at the bottom of the vessel.
8. The final oil was transferred into oral syringes for storage and dosing.

Appearance and Physical Characteristics

Traditional RSO was an extremely dark—nearly black—thick, viscous, tar-like oil. It had a strong cannabis odor and could carry a faint solvent-residual smell depending on how thoroughly the solvent was purged. The consistency was sticky and difficult to handle at room temperature but became more fluid when warmed slightly.

Cannabinoid Profile

• Primarily decarboxylated delta-9 THC. The heat involved in solvent evaporation converted essentially all THCa in the extract into delta-9 THC. Traditional RSO was therefore an activated, THC-dominant product.
• Naturally occurring minor cannabinoids. Whatever CBD, CBN, CBC, CBG, and other minor cannabinoids the source strain contained were present at their natural ratios, but these were not controlled, measured, or targeted.
• No ratio control. There was no ability to adjust or standardize specific cannabinoid ratios. The profile was entirely determined by the genetics and growing conditions of the source plant.
• Estimated THC content. Depending on starting material, traditional RSO likely ranged from approximately 60 to 90 percent total THC by weight, though this was never lab-verified in the traditional production context.

Terpene Content

Minimal to none. The combination of solvent extraction (which dissolves terpenes into the solvent along with cannabinoids) and the subsequent high-heat evaporation process (which volatilizes terpenes at temperatures well below cannabinoid degradation thresholds) meant that traditional RSO was effectively stripped of its terpene content.

Standardization and Testing

None. Every batch of traditional RSO was different because it depended entirely on the starting plant material, growing conditions, solvent purity, extraction technique, evaporation temperature and duration, and the individual maker’s process. There was no Certificate of Analysis, no cannabinoid quantification, and no contaminant screening.

Residual Solvent Risk

This is one of the most significant safety concerns with traditional RSO production. Naphtha and isopropyl alcohol are not food-grade solvents. Naphtha in particular is a complex mixture of petroleum hydrocarbons that may contain benzene, toluene, xylene, and other compounds classified as toxic or carcinogenic. Incomplete solvent purging—which is very difficult to verify without lab testing—leaves potentially harmful residues in the finished oil.

Simpson’s Claims vs. The Evidence: What Alexander County Needs to Know

Rick Simpson made expansive therapeutic claims about his oil. He stated that RSO could cure cancer—including terminal cases—and that it was effective against diabetes, chronic pain, infections, glaucoma, arthritis, depression, insomnia, multiple sclerosis, and numerous other conditions. He was adamant, consistent, and public about these claims throughout his advocacy career .

For Alexander County residents facing serious health challenges, it’s critical to understand what the actual evidence shows:

What Simpson Was Not

Simpson was not a scientist, physician, pharmacologist, or researcher. He had no formal training in medicine, oncology, pharmacology, or clinical research methodology. He never designed, conducted, funded, or published a clinical trial. He never submitted his results to peer review. His entire evidence base consisted of personal experience, self-reported patient outcomes, and testimonials gathered informally—with no controls, no independent verification, no imaging confirmation, no long-term follow-up, and no blinding.

What The Preclinical Literature Shows

The preclinical cannabinoid-cancer literature does exist, and it is scientifically interesting:

• In vitro studies have demonstrated that THC and CBD can induce apoptosis (programmed cell death), inhibit proliferation, and reduce angiogenesis (blood vessel formation that feeds tumors) in certain cancer cell lines .
• Animal model studies have shown some tumor-growth inhibition in mice and rats treated with cannabinoids .
• These findings have generated legitimate scientific interest and ongoing research.

What The Preclinical Literature Does NOT Show

• These findings have not translated into proven human cancer cures. The gap between in vitro or animal results and human clinical outcomes is vast, well-documented across all of oncology research, and especially relevant here.
• No human clinical trial has demonstrated that RSO or any cannabis oil preparation cures cancer.
• Several small human trials of cannabinoids in cancer contexts (particularly glioblastoma) have been conducted, but they have been exploratory, small, and have not produced the kind of results that would support cancer-cure claims .

Institutional Positions

• The U.S. National Cancer Institute (NCI) acknowledges that cannabinoids have been studied for potential anticancer effects in laboratory and animal models but does not endorse cannabis or cannabis oil as a cancer treatment .
• The U.S. Food and Drug Administration (FDA) has not approved any cannabis plant product for the treatment of cancer. The only FDA-approved cannabinoid-related products are for other specific indications: Epidiolex (CBD) for certain seizure disorders and dronabinol/nabilone (synthetic THC analogues) for chemotherapy-related nausea and AIDS-related wasting [1].
• Health Canada has never approved RSO or cannabis oil as a cancer cure.
• NCCIH explicitly states that the strongest cannabinoid evidence is for rare epilepsies, chemotherapy-related nausea and vomiting, and appetite-related indications in HIV/AIDS—not cancer cure [1].

What Simpson Got Right

Simpson drew attention to cannabinoids as a serious area of biomedical research at a time when most of the world was ignoring or actively suppressing that conversation. His advocacy—however scientifically imprecise—helped create the political, cultural, and social conditions for the legal cannabis industry and the cannabinoid research infrastructure that exists today. He was among the first to bring concentrated cannabis oil to widespread public awareness, and the term RSO itself remains the most recognized name for full-spectrum cannabis extract in the consumer vocabulary. These contributions are real and historically significant.

What He Overstated

The leap from preclinical signals to cancer cure was not supported by human evidence when Simpson made it, and it is not supported now. Encouraging patients—particularly cancer patients—to rely on RSO as a primary treatment in place of proven oncologic therapies (surgery, radiation, chemotherapy, immunotherapy) carries genuine harm potential. Delayed or foregone treatment for treatable cancers is a documented concern in the alternative-medicine literature. Simpson’s absolute certainty about curative claims, while understandable from a personal-experience perspective, exceeded what the evidence could support and still exceeds it today.

The Legacy and Evolution: From Traditional RSO to Modern Formulations

The term RSO is now used broadly—and often loosely—across the legal cannabis industry. Many products labeled as RSO bear little resemblance to what Simpson originally made. In dispensaries today, RSO can refer to almost any full-spectrum cannabis extract sold in a syringe format, regardless of extraction method, cannabinoid profile, terpene content, or intended use. The term has become generic .

Simpson himself has been critical of commercial products that use the RSO name while departing significantly from his original method and philosophy. He has publicly stated that many products sold as RSO do not meet his standards and that the commercialization of cannabis oil contradicts his original intent. Simpson’s model was explicitly anti-commercial—he gave the oil away for free and urged others to make their own rather than buy from companies .

This philosophical tension is worth acknowledging. Simpson believed in a do-it-yourself, free-access model in which anyone could grow cannabis, extract the oil, and treat themselves or their loved ones without corporate or governmental intermediaries. The modern cannabis industry has done something very different: it has commercialized, standardized, and regulated what Simpson distributed for free.

What is not in dispute is that modern RSO has evolved substantially from its origins, and those changes are directly relevant to the formulas we offer to Alexander County residents.

Traditional RSO vs. Modern Formulated RSO

Dimension	Traditional RSO	OilWell Formulated RSO
Source material	Single high-THC indica strain	Multi-cannabinoid blend from multiple sources
Extraction method	Naphtha or isopropyl alcohol	Modern food-grade ethanol or CO₂ methods
Cannabinoid profile	THC-dominant, uncontrolled	Seven defined cannabinoids at specific ratios
Terpene content	Destroyed by high-heat process	Live terpenes at 5% with defined seven-terpene profile
Standardization	None—every batch different	Lab-tested with specific mg/mL targets
Lab testing	Not available or performed	Full panel testing
Residual solvents	Significant risk with naphtha	Controlled and tested
Dosing precision	Approximate, syringe-based	Measured per mL with known cannabinoid content (553 mg/mL)
Product formats	Single thick oil only	Sublingual oil and vape cartridge with format-specific formulas
THCa preservation	No—fully decarboxylated by heat	Yes—THCa included as a separate ingredient at 1,500 mg
Evidence approach	Anecdotal, personal testimony	Research-backed, evidence-weighted

Why Our Formulas Diverge: Building Something Better for Alexander County

Our formulations are not traditional RSO. They are informed by the RSO tradition but depart from it in several deliberate, evidence-motivated ways that directly address the challenges Alexander County residents face:

Multi-Cannabinoid Approach

Traditional RSO relied on whatever single strain the maker grew or sourced. Our formulas intentionally include seven cannabinoids—CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, and CBC—because the entourage-effect literature suggests potential benefit from cannabinoid diversity, even though robust clinical proof of whole-formula synergy remains limited [20][29]. For Alexander County residents dealing with complex conditions like chronic pain, PTSD, or cancer treatment side effects, this multi-pathway approach matters.

Terpene Preservation and Addition

Traditional RSO had essentially no terpene content due to solvent and heat destruction. We include live terpenes at 5 percent with a specific seven-terpene profile—limonene, myrcene, caryophyllene, pinene, linalool, humulene, and terpinolene—because terpene bioactivity is plausible and supported at the preclinical level, even if human clinical confirmation for cannabis-specific terpene effects is still developing [20][21][23][24][25][26][27][28][29]. These terpenes give our products a rich sensory profile that connects to Alexander County’s natural environment—the pine forests, agricultural landscapes, and familiar herbal aromas of southern Illinois.

THCa as a Separate Ingredient

Traditional RSO fully decarboxylated everything, converting all THCa into delta-9 THC. Our sublingual formula includes THCa at 1,500 mg as a distinct ingredient, preserving the acidic precursor because the THCa literature suggests potentially relevant non-psychoactive bioactivity that is lost when THCa converts to THC [12]. This gives Alexander County residents who need to work, drive, or parent during the day a non-psychoactive option—critical for our rural communities where daily responsibilities don’t pause.

Reduced Delta-9 THC Dominance

Traditional RSO was overwhelmingly delta-9 THC—often 60 to 90 percent of total cannabinoid content. Our sublingual formula uses delta-9 THC at only 90 mg while incorporating delta-8 THC at 6,000 mg and distributing the remaining cannabinoid content across CBD (4,500 mg), CBG (3,000 mg), CBN (750 mg), and CBC (750 mg). This reflects the broader cannabinoid research landscape rather than a single-compound dominance model, reducing the risk of the intense psychoactive effects that can make traditional RSO unusable during daily life.

Product Format Innovation

Simpson envisioned only one format: an oral oil administered from a syringe. We offer both a 30 mL sublingual oil and a 1-gram vape cartridge, each with its own format-specific formulation acknowledging that different delivery routes have different pharmacokinetic profiles [14]. For Alexander County residents dealing with acute breakthrough pain or panic attacks, the vape’s 1-2 minute onset can be life-changing.

The OilWell Story: From the Border to Alexander County

OilWell Cannabis was founded by Colin Valencia in Houston, Texas. But our story doesn’t start in a corporate boardroom—it starts in McAllen, Texas, right across the river from Reynosa, Tamaulipas, Mexico. The McAllen-Reynosa area, known as the Borderplex, is one of the most economically challenged and dangerous regions along the U.S.-Mexico border. Colin grew up seeing friends killed or imprisoned, learning early that when systems fail people, you have to find your own solutions.

That experience—of living in a place where conventional safety nets were absent—shapes how we approach serving Alexander County. We understand that rural communities like yours face their own versions of systemic gaps: limited specialist access, long drives to healthcare facilities, and a medical system that sometimes treats small-town patients as afterthoughts.

Colin later became a formally trained software engineer and did custom development work for Baylor College of Medicine, one of the most prestigious medical institutions in the Texas Medical Center. That combination—deep cannabis plant knowledge plus medical-grade technical precision—defines our approach and ensures Alexander County residents get products designed with pharmaceutical precision.

Bentley’s Story: The Foundation of Everything

The company’s origin story begins with a dog named Bentley. Bentley was more than just a pet—he was family, a companion who stood by Colin through the toughest times. When Bentley fell seriously ill, veterinarians delivered the verdict no pet owner wants to hear: euthanasia was the only humane option. Bentley was paralyzed in his back legs. They said the pain medications would destroy his internal organs, causing him more pain and suffering. The choice was painful prolonged decline or immediate mercy killing.

But giving up on Bentley was not an option. In a desperate search for alternatives, Colin stumbled upon the healing properties of CBD—through a question that changed everything.

A kind-hearted rescue worker named Jessica asked Colin: “You’ve moved how many tons of weed and you’ve never heard of CBD?”

Colin had cannabis experience—but it was recreational. He had never explored the therapeutic and medicinal applications. Jessica’s question exposed a blind spot that would become a mission.

Determined to save Bentley, Colin learned to create CBD golden paste—a specialized cannabinoid formula for pets. It was not a cure, but it was a lifeline—and it was hope. And that hope delivered something veterinary medicine said was impossible: Bentley got up. He walked over to Colin and brought him his ball to play. From paralyzed and facing euthanasia to fetching his ball. This was not placebo effect—dogs do not respond to placebo. This was cannabinoid medicine doing what pharmaceuticals could not.

Bentley lived another ten years, passing naturally at age twenty. During those ten years, Colin developed specialized cannabis formulas for every age-related condition Bentley faced. Neurodegeneration led him to understand CBG’s neuroprotective properties and THCa’s PPARγ agonism for brain cell protection. Dementia led him to CBC’s role in neurogenesis. Glaucoma led him to THC’s CB1 agonism for intraocular pressure reduction. Crippling arthritis led him to develop multi-pathway anti-inflammatory approaches using CBD, CBG, THCa, and beta-caryophyllene working through different receptor systems simultaneously.

Why this matters for Alexander County: Single cannabinoids were not enough for Bentley. Your complex health challenges—whether it’s chronic pain from years of agricultural work, PTSD from military service, or the multifaceted symptoms of cancer treatment—require the same multi-cannabinoid synergy that kept Bentley alive for a decade. The pharmaceutical precision that mattered for Bentley’s life is the same precision we bring to every bottle we ship to Cairo, Thebes, and Tamms.

Colin’s Personal Battle: PTSD, Benzo Addiction, and the Birth of Peace

Colin also knows pharmaceutical dependence personally. He struggled with PTSD and benzodiazepine addiction. When he decided to break free from Xanax, he did it cold turkey—a feat that is notoriously difficult and dangerous—using the cannabinoid knowledge he had developed keeping Bentley alive. The Peace Gummies formula that became an OilWell product was created during midnight experiments while fighting through benzo withdrawal. To ensure quick relief, OilWell also offers the Peace Gummies formula in a vape form, which Colin personally uses to manage his insomnia and severe PTSD.

This is not theoretical knowledge. Colin lived what RSO patients live: desperation for relief, failed pharmaceuticals, the discovery that cannabinoids work when pills do not. That’s the perspective we bring to serving Alexander County veterans, trauma survivors, and anyone trapped in prescription cycles that don’t work.

ABC13 Media Recognition: Seven Features, One Voice of Authority

Between September 2019 and April 2023, ABC13 Houston (KTRK)—the ABC affiliate serving America’s fourth-largest city—featured Colin Valencia and OilWell Cannabis in seven distinct news segments spanning business, law, medicine, community health, and politics. Five different reporters sought Colin out across those years: Tom Abrahams, Steve Campion, Shelley Childers, Nick Natario, and KTRK staff writers.

Why this matters for Alexander County: No other Houston cannabis operator appears with that frequency or across that breadth of subject matter. When major media repeatedly selects the same voice to explain complex cannabis issues to millions of viewers, it’s because that voice has demonstrated consistent accuracy, honesty, and expertise. Alexander County residents can trust that our company has been vetted by mainstream journalism in ways most online cannabis brands have not.

The Foundational Quote (September 2019)

From our first ABC13 feature, Colin established our philosophy: “I’m not trying to sell people snake oil. I’m not trying to sell people hope, but there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.”

Delta-8 Honesty (May 2021)

When investigative reporter Steve Campion asked why someone would want to use Delta-8 THC, Colin’s response became iconic: “I don’t give a sh* if it’s wrong to say you’ll get high off it. Maybe you want to get high.”* That uncensored honesty on mainstream television—preserved by the network—demonstrates our commitment to telling the truth about psychoactive effects, not hiding them.

Community Health Leadership (August 2021)

During the COVID-19 pandemic, OilWell gave away 1,000 caviar pre-rolls valued at approximately $35,000 to encourage vaccination in Houston. We coordinated with the city government and had no political agenda—just a desire to help our community. That same community-first approach extends to Alexander County: we ship to your area because we believe rural Illinois residents deserve the same access to quality cannabinoid products as urban Texans.

Ethical Crisis Management (October 2021)

When Texas abruptly classified Delta-8 as Schedule I, Colin proactively removed all products before enforcement and warned other operators who were unknowingly shipping what had become illegal narcotics. We absorbed a major revenue loss to act ethically—because that’s the kind of company Alexander County residents can trust.

Personal Conviction History (October 2022)

In our most personal feature, Colin revealed he has previously faced charges for marijuana possession: “You face challenges with housing, loans, and banking, I mean with about everything.” He also stated: “I would love to see people not get hurt for this anymore.” This isn’t a corporate executive talking—it’s someone from the cannabis community who has lived the consequences and is building a better, legal path forward.

The Renaissance Framing (April 2023)

Our most recent feature captured Colin’s perspective on the industry’s future: “Right now is actually a pretty – like Renaissance – pretty important time that should be enjoyed now.” For Alexander County residents watching cannabis laws evolve in Illinois and across the country, this captures the opportunity of the present moment.

The Complete Scientific Evidence: Every Compound, Every Study

For Alexander County’s research-savvy residents—perhaps those connected to Southern Illinois University or simply committed to understanding the science—we provide the complete evidence profile for every cannabinoid and terpene in our formulas. This is the same research framework we use internally, published openly because you deserve to see it.

Cannabinoids: What The Evidence Actually Says

CBD (Cannabidiol) – 4,500mg in our formula

Evidence profile: Strongest human evidence in our formula set, especially when studied as purified product [1]-[6].

What is best supported: Purified CBD has the most credible human evidence in seizure disorders, acknowledged by institutional and peer-reviewed literature [1][2].

Anxiety: A 2024 systematic review and meta-analysis covering 316 participants across eight eligible articles reported a statistically significant anxiolytic signal, but authors stressed that the clinical sample remains limited and more trials are needed [3].

Pain: A 2024 systematic review of clinical and preclinical CBD monotherapy studies concluded that the pain literature is promising but heterogeneous, with trial quality limiting confidence in broad analgesic claims [4].

Sleep: A 2023 insomnia review found that literature remains methodologically weak, with many studies relying on nonvalidated subjective measures [5].

Safety concerns: A 2023 systematic review found real signal for liver enzyme elevation and possible drug-induced liver injury, especially relevant for concentrated oral products and polypharmacy settings [6]. NCCIH flags diarrhea, sleepiness, appetite changes, mood effects, liver-function abnormalities, and drug interactions [1].

Bottom line for Alexander County: CBD is the most evidence-developed nonintoxicating cannabinoid, but strong evidence is concentrated in specific indications rather than broad wellness claims.

CBG (Cannabigerol) – 3,000mg in our formula

Evidence profile: Mostly review-level and preclinical; human evidence remains sparse [7][8].

Pharmacology: CBG is the biosynthetic precursor to several major cannabinoids with interactions spanning cannabinoid receptors, alpha-2 adrenoceptors, and 5-HT1A-related signaling—mechanistically interesting but not yet clinically established [7].

Research areas: Reviews discuss possible relevance to neurologic disorders, inflammatory bowel disease, and antibacterial activity, but these are primarily pharmacology-led hypotheses [7][8].

Caution: The 2021 pharmacology review notes CBG is already being sold commercially while the evidence base remains thin [7].

Bottom line for Alexander County: CBG is a serious research topic but should be described as promising with limited clinical validation rather than proven therapeutic.

Delta-8 THC – 6,000mg in our formula

Evidence profile: Pharmacologically relevant, psychoactive, and much less clinically characterized than delta-9 THC [9]-[11].

Comparative pharmacology: A 2022 review concluded delta-8 and delta-9 THC have broadly similar pharmacokinetic and pharmacodynamic behavior. Delta-8 is a partial CB1 agonist with cannabimimetic activity, but appears less potent than delta-9, likely due to weaker CB1 affinity [9].

Public health literature: A 2023 scoping review found the evidence base dominated by animal studies, product chemistry, use reports, and public-health concerns rather than strong modern human trials. Reports of adverse consequences emphasize regulatory and product-quality concerns [10].

Manufacturing context: Commercial delta-8 interest is tied to greater stability and easier synthesis relative to naturally scarce plant levels, raising product-byproduct and lab-testing questions [11].

Bottom line for Alexander County: Delta-8 THC should be treated as a psychoactive THC analogue with real pharmacologic activity, incomplete human safety characterization, and manufacturing-quality uncertainty.

THCa (Tetrahydrocannabinolic Acid) – 1,500mg in our formula

Evidence profile: Important chemically and formulation-wise, but low on direct human therapeutic evidence [12].

What it is: THCa is the acidic precursor of THC and may represent a very large share of THC-related content in raw plant material. It decarboxylates into THC during heating and can change over time during storage and processing [12].

Psychoactivity: THCa itself does not produce psychoactive effects associated with THC, but this distinction only holds if the molecule stays in its acidic form [12].

Research status: In vitro and rodent literature suggest anti-inflammatory, immunomodulatory, neuroprotective, and antineoplastic possibilities, but these are not equivalent to established human outcomes [12].

Bottom line for Alexander County: THCa is best understood as a highly relevant precursor molecule whose interpretation depends heavily on route, temperature, processing, and storage.

Delta-9 THC – 90mg in our formula

Evidence profile: Strongest human evidence of psychoactive cannabinoids listed, but also clearest adverse-effect burden [1][13]-[15].

Institutionally best supported: NCCIH identifies THC-containing medicines as relevant to chemotherapy-related nausea/vomiting, appetite/weight loss in HIV/AIDS, and some multiple-sclerosis- and pain-related outcomes [1].

Pain evidence: A 2022 systematic review found products with high THC content may provide short-term pain benefit but also increase dizziness, sedation, nausea, and treatment discontinuation [13].

Pharmacokinetics: Inhaled THC produces effects within seconds to minutes, peaks in 15-30 minutes, and tapers over a few hours; oral THC has later onset, later peak, and longer duration [14].

Mental health risk: A 2025 systematic review of high-concentration THC products found consistent unfavorable associations with psychosis/schizophrenia outcomes and cannabis use disorder, with concerning signals for anxiety and depression [15].

Safety: Literature describes anxiety/panic at high doses, tachycardia, blood-pressure changes, dependency potential, withdrawal symptoms, pregnancy concerns, accidental pediatric exposure, and vape-related lung injury [1][14][15].

Bottom line for Alexander County: Delta-9 THC has legitimate therapeutic relevance but carries the clearest intoxication, psychiatric, and dose-related safety liabilities.

CBN (Cannabinol) – 750mg in our formula

Evidence profile: Weak human evidence; marketing has moved ahead of data [12][16][17].

Sleep claims: The 2021 narrative review on CBN and sleep screened 99 human-study abstracts, reviewed eight full-text articles, and found no clinical trials using validated sleep questionnaires or polysomnography that could substantiate strong sleep-promoting claims [16].

Broader sleep literature: The 2024 updated review concluded overall cannabinoid sleep research still doesn’t match real-world use scale, and need for better-designed trials remains substantial [17].

Chemical context: THC can degrade toward CBN under certain conditions, explaining why CBN is often discussed in aging cannabis chemistry [12].

Bottom line for Alexander County: CBN is one of the clearest examples where cultural reputation is stronger than current clinical evidence.

CBC (Cannabichromene) – 750mg in our formula

Evidence profile: Emerging, intriguing, and still overwhelmingly preclinical or review-based [18][19].

Pharmacology: The 2024 focused review argues CBC has distinct pharmacodynamics, pharmacokinetics, and receptor behavior, highlighting antinociceptive, antibacterial, and anti-seizure areas as especially interesting research targets [18].

Older literature: Review literature reports anti-inflammatory effects, reduced gut hypermotility, modest rodent analgesic activity, and possible neurobiological or antiproliferative relevance [19].

Safety caution: The 2024 CBC review explicitly notes over-the-counter CBC products are already being sold despite little evidence establishing clinical efficacy or safety [18].

Bottom line for Alexander County: CBC belongs in the category of scientifically credible minor cannabinoids deserving more research, not already-validated clinical actives.

Terpenes: The Aromatic Dimension

Limonene (Citrus-bright notes)

Evidence profile: Largely review and preclinical, with useful safety literature [20]-[22].

Potential activity: 2021 review describes antioxidant, anti-inflammatory, cardioprotective, gastroprotective, immune-modulatory possibilities, but overwhelming share from nonhuman or non-cannabis literature [21].

Safety note: Limonene oxidation products, especially hydroperoxides, are clinically relevant contact allergens [22].

Myrcene

Evidence profile: Mostly preclinical, very limited human evidence [20][23].

Research summary: 2021 myrcene review describes anxiolytic, antioxidant, anti-inflammatory, analgesic properties but explicitly states human studies are lacking [23].

Interpretation caution: Claims that myrcene reliably explains couch-lock or sleep effects remain interesting hypotheses rather than settled clinical facts [20][23].

Caryophyllene (Pepper/spice notes) – 5% in our formula

Evidence profile: Among most mechanistically interesting because of direct cannabinoid-system relevance, but still mostly preclinical [24].

Why it stands out: 2021 focused review describes beta-caryophyllene as selective CB2 receptor agonist, unusual and especially relevant when discussing cannabis terpenes in pharmacologic terms [24].

Research themes: Anti-inflammatory, immunomodulatory, antioxidant, neuroprotective, gastroprotective actions discussed, but human clinical confirmation remains limited [24].

Pinene (Forest-fresh notes)

Evidence profile: Promising preclinical literature, weak human clinical confirmation [20][25].

Brain-health framing: 2021 review found antioxidant, anti-inflammatory, neuroprotective signals justifying future study, but emphasized evidence is mostly preclinical and well-designed clinical trials are lacking [25].

Linalool (Floral, lavender notes)

Evidence profile: Substantial preclinical interest, limited direct clinical confirmation [20][22][25][26].

Research summary: Repeatedly discussed in relation to stress, mood, brain-health pharmacology [25][26].

Safety note: Oxidized linalool hydroperoxides are recognized allergens in dermatitis literature [22].

Humulene (Earthy, woody notes)

Evidence profile: Translationally interesting, but still early [20][27].

Scoping-review findings: 2024 scoping review of 340 articles found broad preclinical evidence for anti-inflammatory effects, with some rodent work suggesting cannabimimetic properties via CB1 and adenosine A2a pathways [27].

Terpinolene (Piney, fruity, sparkling notes)

Evidence profile: One of least clinically characterized terpenes in this file [20][28].

Systematic-review findings: 2021 terpinolene review screened 2,449 records, included 57 studies, concluding evidence base still dominated by in silico, in vitro, and animal studies rather than human trials [28].

Research Limits and Interpretation

• Evidence base is highly uneven. CBD and delta-9 THC support most detailed human-facing statements; rest require more caution [1]-[29].
• Whole-cannabis extract data, purified-molecule data, semisynthetic cannabinoid data, and terpene-only data are not interchangeable.
• Minor cannabinoids and terpenes are commercially interesting precisely because underexplored, but claims around them often become inflated.
• Product quality matters as much as molecule identity. Labeling inaccuracies, contamination, synthesis byproducts, dose variability, and route-dependent pharmacokinetics all materially affect interpretation [1][10][11][14].
• For THCa, chemistry is destiny: storage and heating can change actual exposure profile by converting acidic cannabinoids into neutral cannabinoids such as THC [12].

Common Overstatements to Avoid

• Overstatement: CBN is clinically proven sleep cannabinoid.
  More accurate: Specific sleep evidence for CBN remains weak with no strong validated-trial base [16][17].

• Overstatement: Myrcene is proven human sedative explaining couch-lock.
  More accurate: Myrcene has plausible preclinical bioactivity but direct human proof limited [20][23].

• Overstatement: Terpenes have proven entourage effects in patients.
  More accurate: Entourage hypotheses are influential but robust clinical proof remains limited [20][29].

• Overstatement: THCa is always nonpsychoactive.
  More accurate: THCa itself is not THC but heating/processing can convert THCa into THC [12].

• Overstatement: Delta-8 THC is safe because hemp-derived.
  More accurate: Delta-8 THC is psychoactive, pharmacologically close to delta-9 THC, often entangled with manufacturing/testing concerns [9]-[11].

Our Complete Open-Source Formulas: Transparency You Can Verify

We publish our exact formulas because Alexander County residents deserve to know exactly what they’re getting—and because we honor Rick Simpson’s original ethos of accessibility.

RSO Sublingual Oil Formula

Cannabinoid	Amount (mg)
CBD	4,500mg
CBG	3,000mg
Delta-8 THC	6,000mg
THCa	1,500mg
Delta-9 THC	90mg
CBN	750mg
CBC	750mg
Total Cannabinoids	16,590mg

• Live Terpenes: 5% (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene)
• Format: 30mL bottle
• Active cannabinoids per mL: 553mg
• Base: Organic MCT oil
• Onset: 15-45 minutes (sublingual)
• Duration: 4-6 hours
• Price: $129.99

RSO Vape Cartridge Formula

Cannabinoid	Percentage
CBD	30%
CBG	20%
Delta-8 THC	15%
THCa	10%
CBN	10%
CBC	10%

• Live Terpenes: 5%+
• Format: 1 Gram cartridge
• Battery: 510-thread universal compatibility
• Onset: 1-2 minutes (fastest delivery)
• Duration: 2-4 hours
• Price: $49.99

The Decarboxylation Choice: Why Alexander County Residents Control Their Potency

Traditional RSO was always fully decarboxylated—always psychoactive. Our formula contains 1,500mg of THCa in its acidic, non-psychoactive form, creating three distinct usage options:

Option 1—Raw, no heat: All 1,500mg stays as THCa—completely non-psychoactive. Provides anti-inflammatory activity via COX-2 inhibition and neuroprotective potential via PPARγ agonism [12]. Compatible with work, driving, and daytime use with zero impairment—essential for Alexander County residents who operate farm equipment, commute to jobs in Carbondale or Cape Girardeau, or need functional relief.

Option 2—Fully activated, home decarboxylation: Heating the oil at 260°F (125°C) for 45-60 minutes converts 1,500mg THCa into approximately 1,315mg delta-9 THC. Combined with existing 90mg delta-9 THC, this yields approximately 1,405mg total delta-9 THC. Combined with 6,000mg delta-8 THC, the activated product achieves psychoactive potency comparable to traditional illegal RSO—100% legally because decarboxylation occurs at your discretion after purchase.

Option 3—Vape, auto-decarboxylation: The vape cartridge vaporizes at 400-450°F, instantly converting THCa to delta-9 THC with each inhalation. Every puff delivers freshly decarboxylated cannabinoids—fastest RSO delivery method available.

Conversion chemistry: THCa has molecular weight of 358.47 g/mol. Conversion ratio is approximately 1mg THCa = 0.877mg delta-9 THC after decarboxylation, reflecting loss of CO₂ molecule.

Condition-Specific Usage Contexts for Alexander County Residents

Important disclaimer: Following contexts are informed by cannabinoid research cited above and our formulation rationale. They are not medical prescriptions, not FDA-approved treatment protocols, and not substitute for professional medical care. These products have not been evaluated by Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease. Always consult qualified healthcare provider before using cannabinoid products, especially if you have medical condition, are taking medications, are pregnant or nursing, or have health concerns. Do not operate vehicles or machinery while under influence of psychoactive cannabinoids.

Chemotherapy-Related Nausea and Appetite Support

• Pre-chemo: 0.5-1.0mL sublingual approximately 1 hour before treatment
• Acute breakthrough nausea: 2-3 vape puffs for immediate relief (1-2 minute onset)
• Post-chemo: 0.5mL sublingual every 6 hours as needed
• Sleep support: 1.0-2.0mL sublingual before bed (delivers 25-50mg CBN)
• Evidence: delta-8 THC antiemetic [9], delta-9 THC nausea/vomiting [1][13], CBD anxiolytic buffering [3]

Chronic Pain (Agricultural Injuries, Arthritis, Neuropathy)

• Daytime: 0.3-0.5mL raw sublingual—provides anti-inflammatory cannabinoid exposure without psychoactive impairment
• Nighttime: 0.5-1.0mL decarboxylated sublingual—combines pain relief with CBN sleep support
• Breakthrough pain: Vape as needed for rapid onset
• Evidence: CBD pain evidence [4], delta-9 THC pain evidence [13], beta-caryophyllene CB2 agonism [24], THCa COX-2 inhibition [12]

Sleep Support (Insomnia, Disrupted Sleep from Pain or PTSD)

• Before bed: 1.0-2.0mL sublingual
• At 2.0mL: Delivers 50mg CBN—dosage level investigated in 2024 sleep literature
• At 1.0mL: Delivers 25mg CBN—above 20mg threshold associated with reduced sleep disturbance
• Evidence: CBN sleep evidence [16][17], cannabis and sleep review literature

Anxiety and Stress (PTSD, Generalized Anxiety)

• Daytime functional relief: 0.3mL raw sublingual—CBD and CBG address anxiety-related pathways without impairment
• Nighttime: 1.0mL sublingual—full cannabinoid profile including CBN for sleep architecture
• Evidence: CBD anxiety evidence [3], CBG pharmacology [7][8], limonene entourage-effect evidence [20]

General Titration Principle

Start low, go slow. Begin with 0.25-0.5mL sublingual and assess effects over 2-3 hours before increasing. Individual responses vary based on body weight, metabolism, tolerance, concurrent medications, and other factors.

Farm Bill Compliance and Legal Framework for Alexander County

The 2018 Farm Bill legalized hemp and hemp-derived products containing less than 0.3% delta-9 THC by dry weight at federal level. Our RSO Sublingual Oil contains only 90mg delta-9 THC in entire 30mL bottle—3mg per mL—well under 0.3% threshold. All cannabinoids are hemp-derived. Product is legal under federal law and Illinois state law.

THCa legal distinction: THCa is acidic, non-psychoactive precursor to delta-9 THC. It is Farm Bill compliant at point of sale because it has not been converted to delta-9 THC. Customer can decarboxylate THCa into delta-9 THC at home by heating oil at 260°F (125°C) for 45-60 minutes. This means same product can function as non-psychoactive anti-inflammatory OR full-potency psychoactive cannabinoid product—100% at customer’s discretion after purchase.

Important legal notice: THCa converts to delta-9 THC when heated. Customers are responsible for understanding and complying with local laws. We ship with full documentation, Certificates of Analysis, and receipts. International customers accept all customs and legal responsibility.

For Alexander County residents: Illinois has legalized adult-use cannabis, but access in rural southern Illinois can be limited. Our Farm Bill-compliant products provide legal alternative that ships directly to your door without needing medical card or dispensary visit.

Delivery to Alexander County: How You Get Our Products

While our base is in Houston’s Montrose neighborhood, we serve Alexander County residents through comprehensive shipping infrastructure:

Nationwide Shipping to Illinois

• USPS Priority Mail: 2-3 business days to Cairo, Thebes, Tamms, and throughout Alexander County
• FedEx/UPS Ground: 3-5 business days with tracking
• Discreet packaging: No cannabis branding visible on exterior
• Temperature-stable packaging: Ensures product integrity during Illinois summer heat
• Signature-required option: Available for added security
• Tracking provided: For all orders

International Shipping

We ship internationally to jurisdictions compatible with hemp laws. All packages include full documentation, Certificates of Analysis (COAs), and receipts for customs. Customer accepts all customs and legal responsibility.

Why We Ship to Alexander County

We understand that driving from Cairo to Carbondale for dispensary access is a significant burden. We know that rural healthcare access in southern Illinois has unique challenges. Our mission is to bring pharmaceutical-grade, multi-cannabinoid products to your doorstep because you deserve the same options as urban consumers.

The Philosophy That Drives Us: Four Core Principles

1. Accessibility over gatekeeping. No medical card required. Anyone age 21+ can purchase. We ship nationwide and internationally. Simpson believed medicine should be accessible to everyone; we built a product and distribution model that makes that accessible legally—even to Cairo and Thebes.

2. Patient-controlled potency. THCa is sold in acidic, non-psychoactive form. You decide whether to use raw for non-psychoactive benefits or decarboxylate for full psychoactive potency. Simpson believed patients should control their medicine; we engineered product that puts that control in your hands through chemistry.

3. Open-source formulas. We publish complete formulas publicly—every cannabinoid, every milligram—so anyone who cannot afford our products can source ingredients and make their own. Simpson gave oil away free; we adapted that ethos for modern marketplace by selling professional product AND publishing recipe.

4. Evidence-informed, not evidence-overstating. Our GENERAL KNOWLEDGE section represents our commitment to honest education about what science actually says. Simpson operated without peer-reviewed literature; we have that access and use it to distinguish what is well-supported, emerging, or overstated.

How Our Formulas Connect to The Complete Evidence

Every cannabinoid in our formulas—CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, CBC—has its own evidence profile with specific peer-reviewed citations and evidence-tier assessments. Every terpene—limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene—is covered with preclinical and review-level evidence.

Where we make specific research claims about individual compounds, this document provides source evaluation context—the same peer-reviewed citations [1]-[29], same evidence-tier assessments, same cautious interpretation framework. We do not exempt ourselves from evidence standards applied to broader field. That is intentional. As Colin stated in 2019: people deserve best possible version of information so they can give it fair shot and decide for themselves whether it is right or wrong for them.

Bentley’s Original CBD Golden Paste Recipe: Still Free for Alexander County Pet Owners

Our open-source philosophy started before RSO—it started with Bentley. We published the actual CBD golden paste recipe that saved Bentley’s life, so any Alexander County pet owner facing similar crisis can make it themselves:

Ingredients:

• 1/2 cup organic turmeric powder
• 1 cup water
• 1/3 cup coconut oil (unrefined, organic)
• 1-2 teaspoons freshly ground black pepper (important for absorption)
• CBD oil (dosage depends on pet size and needs; consult veterinarian)

Instructions:

1. Mix turmeric and water in saucepan over low heat, stirring continuously until thick paste forms (7-10 minutes). Add more water if too thick.
2. Add coconut oil and pepper, stir until thoroughly mixed.
3. Cool, transfer to jar with lid, refrigerate up to two weeks.
4. Add small amount of CBD oil to paste before giving to pet, adjusting dosage based on weight and health needs. Start low and gradually increase.

Serving suggestion: Mix small amount of golden paste with pet’s food once or twice daily. Monitor for changes and consult veterinarian if concerns arise. Always consult veterinarian before starting any new supplement regimen.

This recipe—published free years before RSO formulas—demonstrates our consistent pattern: give away what saves lives, then build professional products for those who want them.

When to Use Each Format: Decision Guide for Alexander County

Use Case	Recommended Format	Why It Works For You
Fast relief (acute pain, nausea, panic)	Vape cartridge	1-2 minute onset—essential for breakthrough episodes
Sustained relief (chronic pain, sleep)	Sublingual oil	4-6 hour duration—covers full night or workday
Maximum bioavailability	Sublingual oil	13-19% absorption—more medicine reaches bloodstream
Portability/discretion	Vape cartridge	Compact, no measuring—fits in pocket for farm work or travel
Precise dosing control	Sublingual oil	Graduated dropper in 0.1mL increments—critical for titration
Daytime non-psychoactive use	Sublingual (raw)	THCa stays inactive—zero impairment for equipment operation
Nighttime psychoactive use	Sublingual (decarbed) or vape	Activated for full therapeutic strength when you can rest

Competitive Comparison: Why OilWell Stands Out in Alexander County

OilWell RSO vs. Illinois Dispensary RSO

Feature	Illinois Dispensary RSO	OilWell RSO
Cannabinoid profile	Typically THC-dominant only	7 cannabinoids (CBD, CBG, delta-8, THCa, delta-9, CBN, CBC)
CBG/CBN/CBC content	Usually minimal or absent	3,000mg CBG, 750mg CBN, 750mg CBC
Patient-controlled potency	No—always psychoactive	Yes—THCa stays raw until you heat it
Access requirements	Must visit dispensary (nearest may be 50+ miles)	Ships directly to your Alexander County address
Price for equivalent cannabinoids	$60-80 for ~500mg THC	$129.99 for 16,590mg total cannabinoids
Lab testing availability	Variable	Full panel COAs always available

OilWell RSO vs. Hemp CBD Oil (e.g., Lazarus Naturals)

Feature	Typical Hemp CBD Oil	OilWell RSO
Total cannabinoids	1,000mg	16,590mg
Delta-8 THC content	0mg	6,000mg
THCa (convertible)	Minimal	1,500mg → ~1,315mg delta-9 when heated
Psychoactive option	No meaningful effect	Yes—via THCa decarboxylation and delta-8
Price for potency	$40-50	$129.99 (16x more cannabinoids)

Safety Information Every Alexander County Resident Must Know

Age requirement: 21+ for all RSO products.

THC content compliance: All products contain less than 0.3% delta-9 THC; Farm Bill compliant; hemp-derived cannabinoids.

FDA disclaimers: Not evaluated by FDA; not intended to diagnose, treat, cure, or prevent any disease; consult healthcare provider before use; individual results may vary.

Safety warnings: May cause drowsiness or impairment; do not operate vehicles or machinery; consult physician if pregnant or nursing; keep out of reach of children.

Legal responsibility: Buyer responsibility to check local laws; company assumes no legal responsibility for customer’s use or decarboxylation decisions; void where prohibited by law.

Drug testing: Delta-8 THC and activated THCa will trigger positive drug tests. Raw THCa will not. Be honest with employers.

Real Resources for Alexander County Residents

We know that cannabinoids are one part of health picture. Alexander County residents should also know about:

• Alexander County Health Department: (618) 734-4144—public health resources and immunizations
• Cairo Clinic: (618) 734-4411—primary care services
• Southern Illinois Healthcare (Carbondale): (618) 549-0121—nearest major medical center
• Veterans Affairs Clinic (Marion): (618) 993-3350—VA services for Alexander County veterans
• Southern Illinois University School of Medicine: (217) 545-8000—research and specialty care access

Ordering and Contact Information

Phone: (832) 416-2816
Email: [email protected]
Website: https://oilwellcbd.com/
Instagram: @oilwellcbd
Address: 810 Richmond Ave, Houston, TX 77006 (Montrose neighborhood)

Business Hours:

• Monday-Thursday: 10:00 AM – 7:00 PM
• Friday-Saturday: 10:00 AM – 10:00 PM
• Sunday: 10:00 AM – 4:00 PM

The Final Word for Alexander County

We built OilWell Cannabis because we believe people deserve honest, effective, accessible cannabinoid medicine—not hype, not gatekeeping, and certainly not the dangerous solvents and unknown potencies of traditional RSO. We serve Alexander County because we know rural Illinois residents face the same struggles our Houston community faces: pain that pills don’t touch, sleep that won’t come, anxiety that won’t quit, and a medical system that sometimes runs out of answers.

From Cairo’s riverfront to Thebes’ historic streets, from Tamms’ quiet neighborhoods to the farms stretching across Alexander County’s landscape—we see you. We understand your need for reliable, legal, lab-tested cannabinoid products that you can actually afford and actually trust.

Our promise: We’ll never sell you snake oil. We’ll never overstate what the evidence shows. We’ll always publish our formulas. And we’ll always ship to Alexander County with the same care we show our Houston neighbors.

Because when Bentley got up and brought his ball to Colin, that wasn’t just a miracle for one dog. It was the moment that proved cannabinoids could do what medicine said was impossible. That same science, that same dedication, that same hope—is what we offer to Alexander County.

Ready to give it a fair shot? We’re here. Call us. Email us. Visit our website. We’ll answer every question with the same honesty that’s earned us seven ABC13 features and the trust of thousands of customers across six continents.

Order today. Ship to Alexander County. Experience the difference real science makes.